 - No addition or subtraction of other immunosuppressive medications. The dose of immunosuppressive medicines may be adjusted based on the therapeutic range of that drug. However, if cGVHD occurs during a taper of immune suppression, the medications may not be increased back up to therapeutic level, but will continue a the taper dose for the 15 week study duration 